During the discussion, Director of Russian Direct Investment Fund Vladimir Primak, introduced an overview of the Sputnik V vaccine, the first Russian-licensed SARS-CoV-2 vaccine.

(Photo for illustration)

According to Mr. Primak, Sputnik V is a direct injection vaccine consisting of two doses, and the second injection will be taken 21 days after the first one. The vaccine has passed phase-two of its clinical trial and been proven to build an immune system against the coronavirus.

The Russian Director also answered questions about the vaccine, affirming they are willing to share pre-clinical research records; clinical trial records of the vaccine in phase 1 and phase 2 after the two sides reach an information security agreement.

For his part, General Kien said amid the complicated development of COVID-19 pandemic, some countries, including Russia, took a vanguard role in anti-SARS-CoV-2 vaccine search and production.

General Kien also congratulated Russia on their achievements in studying and manufacturing the Sputnik V vaccine, affirming the Vietnamese military medicine is ready to work with Russia in testing the vaccine for the coronavirus with the permission of relevant authorities.

Translated by Khanh Ngan